カテゴリ： 世界, 医療/バイオ, QYResearch

プロトロンビン複合体濃縮物（PCC）医薬品の世界市場2023年：500 IU/バイアル、600 IU/バイアル、1000 IU/バイアル、その他

■ 英語タイトル：Global Prothrombin Complex Concentrate (PCC) Drug Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8874）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8874
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[プロトロンビン複合体濃縮物（PCC）医薬品の世界市場2023年：500 IU/バイアル、600 IU/バイアル、1000 IU/バイアル、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はプロトロンビン複合体濃縮物（PCC）医薬品のグローバル市場について調査・分析し、世界のプロトロンビン複合体濃縮物（PCC）医薬品市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（500 IU/バイアル、600 IU/バイアル、1000 IU/バイアル、その他）、用途別セグメント分析（血友病B、ビタミンK欠乏症、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Takeda、CSL Behring GmbH、Grifols Biologicals、Octapharma、Hualan Biological、Meheco Xinxing Pharmaなどが含まれています。プロトロンビン複合体濃縮物（PCC）医薬品のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、プロトロンビン複合体濃縮物（PCC）医薬品市場規模を算出する際に考慮しました。

・プロトロンビン複合体濃縮物（PCC）医薬品市場の概要
- 製品の定義
- プロトロンビン複合体濃縮物（PCC）医薬品の種類別セグメント
- 世界のプロトロンビン複合体濃縮物（PCC）医薬品市場規模：タイプ別分析（500 IU/バイアル、600 IU/バイアル、1000 IU/バイアル、その他）
- プロトロンビン複合体濃縮物（PCC）医薬品の用途別セグメント
- 世界のプロトロンビン複合体濃縮物（PCC）医薬品市場規模：用途別分析（血友病B、ビタミンK欠乏症、その他）
- 世界のプロトロンビン複合体濃縮物（PCC）医薬品市場規模予測（2018年-2029年）
- プロトロンビン複合体濃縮物（PCC）医薬品の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- プロトロンビン複合体濃縮物（PCC）医薬品市場の競争状況およびトレンド

・プロトロンビン複合体濃縮物（PCC）医薬品の地域別市場規模
- 北米のプロトロンビン複合体濃縮物（PCC）医薬品市場規模（2018年-2029年）
- 米国のプロトロンビン複合体濃縮物（PCC）医薬品市場規模（2018年-2029年）
- ヨーロッパのプロトロンビン複合体濃縮物（PCC）医薬品市場規模（2018年-2029年）
- アジア太平洋のプロトロンビン複合体濃縮物（PCC）医薬品市場規模（2018年-2029年）
- 中国のプロトロンビン複合体濃縮物（PCC）医薬品市場規模（2018年-2029年）
- 日本のプロトロンビン複合体濃縮物（PCC）医薬品市場規模（2018年-2029年）
- 韓国のプロトロンビン複合体濃縮物（PCC）医薬品市場規模（2018年-2029年）
- インドのプロトロンビン複合体濃縮物（PCC）医薬品市場規模（2018年-2029年）
- オーストラリアのプロトロンビン複合体濃縮物（PCC）医薬品市場規模（2018年-2029年）
- 中南米のプロトロンビン複合体濃縮物（PCC）医薬品市場規模（2018年-2029年）
- 中東・アフリカのプロトロンビン複合体濃縮物（PCC）医薬品市場規模（2018年-2029年）

・種類別セグメント：500 IU/バイアル、600 IU/バイアル、1000 IU/バイアル、その他
- 世界のプロトロンビン複合体濃縮物（PCC）医薬品のタイプ別販売量（2018年-2023年）
- 世界のプロトロンビン複合体濃縮物（PCC）医薬品のタイプ別売上（2018年-2023年）
- 世界のプロトロンビン複合体濃縮物（PCC）医薬品のタイプ別価格

・用途別セグメント：血友病B、ビタミンK欠乏症、その他
- 世界のプロトロンビン複合体濃縮物（PCC）医薬品の用途別販売量（2018年-2023年）
- 世界のプロトロンビン複合体濃縮物（PCC）医薬品の用途別売上（2018年-2023年）
- 世界のプロトロンビン複合体濃縮物（PCC）医薬品の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Takeda、CSL Behring GmbH、Grifols Biologicals、Octapharma、Hualan Biological、Meheco Xinxing Pharma

・産業チェーンと販売チャネルの分析
- プロトロンビン複合体濃縮物（PCC）医薬品産業チェーン分析
- プロトロンビン複合体濃縮物（PCC）医薬品の主要原材料
- プロトロンビン複合体濃縮物（PCC）医薬品の販売チャネル
- プロトロンビン複合体濃縮物（PCC）医薬品のディストリビューター
- プロトロンビン複合体濃縮物（PCC）医薬品の主要顧客

・プロトロンビン複合体濃縮物（PCC）医薬品市場ダイナミクス
- プロトロンビン複合体濃縮物（PCC）医薬品の業界動向
- プロトロンビン複合体濃縮物（PCC）医薬品市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Prothrombin Complex Concentrate (PCC) Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Prothrombin Complex Concentrate (PCC) Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Prothrombin Complex Concentrate (PCC) Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Prothrombin Complex Concentrate (PCC) Drug include Takeda, CSL Behring GmbH, Grifols Biologicals, Octapharma, Hualan Biological and Meheco Xinxing Pharma, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prothrombin Complex Concentrate (PCC) Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prothrombin Complex Concentrate (PCC) Drug.
The Prothrombin Complex Concentrate (PCC) Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Prothrombin Complex Concentrate (PCC) Drug market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prothrombin Complex Concentrate (PCC) Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Takeda
CSL Behring GmbH
Grifols Biologicals
Octapharma
Hualan Biological
Meheco Xinxing Pharma
Segment by Type
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Segment by Application
Hemophilia B
Vitamin K Deficiency
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prothrombin Complex Concentrate (PCC) Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prothrombin Complex Concentrate (PCC) Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Prothrombin Complex Concentrate (PCC) Drug Market Overview
1.1 Product Overview and Scope of Prothrombin Complex Concentrate (PCC) Drug
1.2 Prothrombin Complex Concentrate (PCC) Drug Segment by Type
1.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Value Comparison by Type (2023-2029)
1.2.2 500 IU/Vial
1.2.3 600 IU/Vial
1.2.4 1000 IU/Vial
1.2.5 Others
1.3 Prothrombin Complex Concentrate (PCC) Drug Segment by Application
1.3.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Application: (2023-2029)
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Global Prothrombin Complex Concentrate (PCC) Drug Market Size Estimates and Forecasts
1.4.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue 2018-2029
1.4.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales 2018-2029
1.4.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Prothrombin Complex Concentrate (PCC) Drug Market Competition by Manufacturers
2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturers (2018-2023)
2.4 Global Prothrombin Complex Concentrate (PCC) Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Product Type & Application
2.7 Prothrombin Complex Concentrate (PCC) Drug Market Competitive Situation and Trends
2.7.1 Prothrombin Complex Concentrate (PCC) Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prothrombin Complex Concentrate (PCC) Drug Players Market Share by Revenue
2.7.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prothrombin Complex Concentrate (PCC) Drug Retrospective Market Scenario by Region
3.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Prothrombin Complex Concentrate (PCC) Drug Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region: 2018-2029
3.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region: 2018-2023
3.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region: 2024-2029
3.3 Global Prothrombin Complex Concentrate (PCC) Drug Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2018-2029
3.3.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2018-2023
3.3.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2024-2029
3.4 North America Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.4.1 North America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2018-2029)
3.4.3 North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.5.1 Europe Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2018-2029)
3.5.3 Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.7.1 Latin America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2018-2029)
3.7.3 Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2018-2029)
4.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2018-2023)
4.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2024-2029)
4.1.3 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2018-2029)
4.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2018-2029)
4.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2018-2023)
4.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2024-2029)
4.2.3 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2018-2029)
4.3 Global Prothrombin Complex Concentrate (PCC) Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2018-2029)
5.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2018-2023)
5.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2024-2029)
5.1.3 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2018-2029)
5.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2018-2029)
5.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2018-2023)
5.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2024-2029)
5.2.3 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2018-2029)
5.3 Global Prothrombin Complex Concentrate (PCC) Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Takeda Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL Behring GmbH
6.2.1 CSL Behring GmbH Corporation Information
6.2.2 CSL Behring GmbH Description and Business Overview
6.2.3 CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.2.5 CSL Behring GmbH Recent Developments/Updates
6.3 Grifols Biologicals
6.3.1 Grifols Biologicals Corporation Information
6.3.2 Grifols Biologicals Description and Business Overview
6.3.3 Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.3.5 Grifols Biologicals Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Hualan Biological
6.5.1 Hualan Biological Corporation Information
6.5.2 Hualan Biological Description and Business Overview
6.5.3 Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.5.5 Hualan Biological Recent Developments/Updates
6.6 Meheco Xinxing Pharma
6.6.1 Meheco Xinxing Pharma Corporation Information
6.6.2 Meheco Xinxing Pharma Description and Business Overview
6.6.3 Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.6.5 Meheco Xinxing Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prothrombin Complex Concentrate (PCC) Drug Industry Chain Analysis
7.2 Prothrombin Complex Concentrate (PCC) Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prothrombin Complex Concentrate (PCC) Drug Production Mode & Process
7.4 Prothrombin Complex Concentrate (PCC) Drug Sales and Marketing
7.4.1 Prothrombin Complex Concentrate (PCC) Drug Sales Channels
7.4.2 Prothrombin Complex Concentrate (PCC) Drug Distributors
7.5 Prothrombin Complex Concentrate (PCC) Drug Customers
8 Prothrombin Complex Concentrate (PCC) Drug Market Dynamics
8.1 Prothrombin Complex Concentrate (PCC) Drug Industry Trends
8.2 Prothrombin Complex Concentrate (PCC) Drug Market Drivers
8.3 Prothrombin Complex Concentrate (PCC) Drug Market Challenges
8.4 Prothrombin Complex Concentrate (PCC) Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Prothrombin Complex Concentrate (PCC) Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Prothrombin Complex Concentrate (PCC) Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Prothrombin Complex Concentrate (PCC) Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Prothrombin Complex Concentrate (PCC) Drug Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Prothrombin Complex Concentrate (PCC) Drug, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Product Type & Application
Table 12. Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Prothrombin Complex Concentrate (PCC) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prothrombin Complex Concentrate (PCC) Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2018-2023) & (K Units)
Table 18. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2018-2023)
Table 19. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2024-2029)
Table 21. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2018-2023)
Table 23. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2018-2023) & (K Units)
Table 27. North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2018-2023) & (K Units)
Table 32. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) by Type (2018-2023)
Table 51. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) by Type (2024-2029)
Table 52. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2018-2023)
Table 53. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2024-2029)
Table 54. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2018-2023)
Table 57. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Type (2018-2023)
Table 59. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Type (2024-2029)
Table 60. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) by Application (2018-2023)
Table 61. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) by Application (2024-2029)
Table 62. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2018-2023)
Table 63. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2024-2029)
Table 64. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2018-2023)
Table 67. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Application (2018-2023)
Table 69. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Application (2024-2029)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Takeda Prothrombin Complex Concentrate (PCC) Drug Product
Table 74. Takeda Recent Developments/Updates
Table 75. CSL Behring GmbH Corporation Information
Table 76. CSL Behring GmbH Description and Business Overview
Table 77. CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Product
Table 79. CSL Behring GmbH Recent Developments/Updates
Table 80. Grifols Biologicals Corporation Information
Table 81. Grifols Biologicals Description and Business Overview
Table 82. Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Product
Table 84. Grifols Biologicals Recent Developments/Updates
Table 85. Octapharma Corporation Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Octapharma Prothrombin Complex Concentrate (PCC) Drug Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Hualan Biological Corporation Information
Table 91. Hualan Biological Description and Business Overview
Table 92. Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Product
Table 94. Hualan Biological Recent Developments/Updates
Table 95. Meheco Xinxing Pharma Corporation Information
Table 96. Meheco Xinxing Pharma Description and Business Overview
Table 97. Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Product
Table 99. Meheco Xinxing Pharma Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Prothrombin Complex Concentrate (PCC) Drug Distributors List
Table 103. Prothrombin Complex Concentrate (PCC) Drug Customers List
Table 104. Prothrombin Complex Concentrate (PCC) Drug Market Trends
Table 105. Prothrombin Complex Concentrate (PCC) Drug Market Drivers
Table 106. Prothrombin Complex Concentrate (PCC) Drug Market Challenges
Table 107. Prothrombin Complex Concentrate (PCC) Drug Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prothrombin Complex Concentrate (PCC) Drug
Figure 2. Global Prothrombin Complex Concentrate (PCC) Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Type in 2022 & 2029
Figure 4. 500 IU/Vial Product Picture
Figure 5. 600 IU/Vial Product Picture
Figure 6. 1000 IU/Vial Product Picture
Figure 7. Others Product Picture
Figure 8. Global Prothrombin Complex Concentrate (PCC) Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Application in 2022 & 2029
Figure 10. Hemophilia B
Figure 11. Vitamin K Deficiency
Figure 12. Others
Figure 13. Global Prothrombin Complex Concentrate (PCC) Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Prothrombin Complex Concentrate (PCC) Drug Market Size (2018-2029) & (US$ Million)
Figure 15. Global Prothrombin Complex Concentrate (PCC) Drug Sales (2018-2029) & (K Units)
Figure 16. Global Prothrombin Complex Concentrate (PCC) Drug Average Price (US$/Unit) & (2018-2029)
Figure 17. Prothrombin Complex Concentrate (PCC) Drug Report Years Considered
Figure 18. Prothrombin Complex Concentrate (PCC) Drug Sales Share by Manufacturers in 2022
Figure 19. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Prothrombin Complex Concentrate (PCC) Drug Players: Market Share by Revenue in 2022
Figure 21. Prothrombin Complex Concentrate (PCC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2018-2029)
Figure 24. North America Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2018-2029)
Figure 28. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2018-2029)
Figure 29. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2018-2029)
Figure 36. China Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Taiwan Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Philippines Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2018-2029)
Figure 47. Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. U.A.E Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Prothrombin Complex Concentrate (PCC) Drug by Type (2018-2029)
Figure 57. Global Revenue Market Share of Prothrombin Complex Concentrate (PCC) Drug by Type (2018-2029)
Figure 58. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Prothrombin Complex Concentrate (PCC) Drug by Application (2018-2029)
Figure 60. Global Revenue Market Share of Prothrombin Complex Concentrate (PCC) Drug by Application (2018-2029)
Figure 61. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Application (2018-2029)
Figure 62. Prothrombin Complex Concentrate (PCC) Drug Value Chain
Figure 63. Prothrombin Complex Concentrate (PCC) Drug Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • チオテパ注射のグローバル市場展望 2023年-2029年：15mg/バイアル、100mg/バイアル
  • ハンドヘルドデジタルクランプマルチメータのグローバル市場展望 2023年-2029年：600 V/100 A、600 V/400 A、600 V/1000 A、1000 V/1000 A
  • 高速ブランキングプレス機のグローバル市場展望 2023年-2029年：180-600 KN、600-1000 KN、1000-2500 KN、その他
  • インフルエンザ菌b型混合ワクチンの世界市場2023年：バイアル、プレフィルド
  • セービン不活化ポリオワクチン（sIPV）の世界市場2023年：バイアル、シリンジ
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8874 )"プロトロンビン複合体濃縮物（PCC）医薬品の世界市場2023年：500 IU/バイアル、600 IU/バイアル、1000 IU/バイアル、その他" (英文：Global Prothrombin Complex Concentrate (PCC) Drug Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。